ASTELLAS PHARMA A/S: Financial statements 2013
CVR: 10888638
Source: annual report 2013, Danish Business Authority
01/04/2012 – 31/03/2013
ASTELLAS PHARMA A/S (CVR 10888638) has filed annual accounts for 2013. In 2013, the company reported revenue of EUR 92,965,000 and a net result of EUR 5,714,000. The profit margin was 6.1%. Equity in the 2013 report amounted to EUR 34,448,000. The solvency ratio was 77.1%. The company had 90 employees in the financial year.
- Revenue
- EUR 92,965,000
- Gross Profit
- EUR 23,561,000
- Profit/Loss
- EUR 5,714,000
- Equity
- EUR 34,448,000
- Total Assets
- EUR 44,705,000
- Employees
- 90
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout ASTELLAS PHARMA A/S
ASTELLAS PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1987. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named YAMANOUCHI PHARMA A/S and BROCADES PHARMA A/S. The management consists of Mark Andree Dekker. The board consists of Damla Ebru Atilgan (chair), Anne Nymand, Giuseppe Maduri and Mark Andree Dekker. The company is owned by Astellas Pharma Europe LTD.. The company has 67 employees (2026). In 2026, the company reported revenue of EUR 197,863,000 and a net result of EUR 5,229,000 compared with EUR 5,705,000 the year before. Equity in the 2026 report amounted to EUR 20,071,000.